North America Smoking Cessation And Nicotine De Addictions Market
Tamanho do mercado em biliões de dólares
CAGR : %
Período de previsão |
2022 –2029 |
Tamanho do mercado (ano base ) | USD 38.58 Billion |
Tamanho do mercado ( Ano de previsão) | USD 221.27 Billion |
CAGR |
|
Principais participantes do mercado |
>Mercado de cessação tabágica e dependência de nicotina da América do Norte, por tipo de produto (com nicotina e sem nicotina), tipo de tratamento (farmacológico, terapias e outros) canal de distribuição (online, offline), utilizador final (geração Z , geração Y, geração X e geração silenciosa) – Tendências e previsões do setor para 2029
Análise e dimensão do mercado
O número de pessoas viciadas em fumar está a crescer rapidamente em todo o mundo. Este subconjunto populacional é constituído principalmente por adolescentes e pela população trabalhadora. A taxa de mortalidade por fumar é extremamente elevada. O desejo crescente de deixar de fumar e os numerosos riscos para a saúde associados ao tabagismo proporcionam fortes incentivos para as empresas desenvolverem novos produtos para deixar de fumar.
A Data Bridge Market Research analisa que o mercado de cessação tabágica e de dependência de nicotina foi avaliado em 38,58 mil milhões de dólares em 2021 e deverá atingir o valor de 221,27 mil milhões de dólares até 2029, com um CAGR de 24, 4% durante o período de previsão de 2022 para 2029.
Definição de mercado
A abstinência do tabaco faz parte da cessação tabágica ou da eliminação da dependência da nicotina. O tabaco contém nicotina, que é conhecida por causar dependência ao libertar neurotransmissores como a dopamina, o ácido gama-aminobutírico (GABA) e o glutamato. A cessação tabágica auxilia no tratamento dos dependentes do cigarro e do tabaco.
Âmbito do relatório e segmentação de mercado
Métrica de relatório |
Detalhes |
Período de previsão |
2022 a 2029 |
Ano base |
2021 |
Anos históricos |
2020 (personalizável para 2019 - 2014) |
Unidades Quantitativas |
Receita em biliões de dólares, volumes em unidades, preços em dólares |
Segmentos cobertos |
Tipo de Produto (Com Nicotina e Sem Nicotina), Tipo de Tratamento (Farmacológico, Terapêuticos e Outros) Canal de Distribuição (Online, Offline), Utilizador Final (Geração Z, Millennials, Geração X e Geração Silenciosa) |
Países abrangidos |
EUA, Canadá e México |
Participantes do mercado abrangidos |
Imperial Brands (Reino Unido), 22nd Century Group, Inc (EUA), Pfizer Inc. Reddy's Laboratories Ltd (Índia), Glaxosmithkline Plc. (Reino Unido), British American Tobacco (Reino Unido), Cambrex Corporation (EUA), Cipla Inc. (EUA), Fertin Pharma (Dinamarca), Johnson & Johnson private Limited (EUA), Perrigo Company Plc (Irlanda) |
Oportunidades |
|
Dinâmica do mercado de cessação tabágica e dependência da nicotina
Motoristas
- Aumento do número de pessoas que tentam deixar de fumar em todo o mundo
One of the major factors driving the growth of the smoking cessation and nicotine de-addiction market is the increase in the number of people attempting to quit smoking around the world. Due to the toxic effects of nicotine and cigarette addiction on the cardiac and respiratory systems, the government emphasizes strict regulations to control nicotine and cigarette addiction, and high taxes on tobacco products accelerate market growth. Furthermore, high adoption of unhealthy lifestyle options, rapid urbanization, and an increase in disposable income all benefit the smoking cessation and nicotine de-addiction market.
- Strict regulations laid down by government to control nicotine and cigarette addiction
The government is emphasising strict regulations to control nicotine and cigarette addiction due to the toxic effects on the cardiac and respiratory systems. Smoking bans in public places, high taxes on tobacco products, and financial support for smoking cessation therapies are examples of government smoking cessation policies. As a result, during the forecast period, the global market for smoking cessation and nicotine de-addiction products is expected to grow rapidly.
Opportunities
The introduction of improved and innovative nicotine replacement therapy products is expected to be a significant driving force in the growth of the smoking cessation and nicotine de-addiction market. The rising prevalence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, as well as growing public awareness of the dangers of smoking, are expected to drive market growth. An educational institution continue to be active in organising various campaigns and programmes to spread information about the harmful effects and consequences of smoking in order to raise the awareness of the young population.
Restraints
Reluctance to accept the treatment, on the other hand, is expected to stymie market growth. The smoking cessation and nicotine de-addiction market is expected to face challenges due to a lack of awareness in the forecast period.
This smoking cessation and nicotine de-addictions market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the smoking cessation and nicotine de-addictions market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Smoking Cessation and Nicotine De-Addictions Market
O diagnóstico de COVID-19 foi cinco vezes mais provável apenas entre os utilizadores de cigarros eletrónicos, mas também está associado ao duplo risco dos cigarros eletrónicos e dos cigarros, o que implica que os cigarros eletrónicos podem ser fatores de risco subjacentes à COVID-19 . O uso do tabaco aumenta o risco de infeção, a probabilidade de complicações e a probabilidade de propagação de doenças. Apenas 30% dos consumidores referiram que a situação actual influenciou o seu consumo de tabaco, sendo as consequências mais comuns a falta de produtos de tabaco e o aumento dos preços. Durante o confinamento, 34% dos consumidores de tabaco da população estudada deixaram de fumar. 51 por cento dos que partiram fizeram-no devido ao confinamento e às suas preocupações com a COVID-19. Como resultado, a pandemia COVID-19 teve um impacto significativo no mercado de auxiliares para deixar de fumar.
Desenvolvimento recente
- A JB Chemicals & Pharmaceuticals vai lançar pastilhas medicamentosas de nicotina em maio de 2021 para ajudar a reduzir o desejo de consumir ou fumar tabaco.
- A NFL Biosciences SA, uma empresa biofarmacêutica que desenvolve medicamentos botânicos para o tratamento da dependência, vai iniciar o seu ensaio clínico CESTO II Fase II/III em dezembro de 2021 para avaliar a eficácia e segurança do seu tratamento para deixar de fumar NFL-101.
Âmbito do mercado de cessação tabágica e dependência de nicotina na América do Norte
O mercado da cessação tabágica e da dependência da nicotina está segmentado com base no tipo de produto, tipo de tratamento, canal de distribuição e utilização final. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para os ajudar a tomar decisões estratégicas para identificar as principais aplicações do mercado.
Tipo de produto
- Com Nicotina
- Sem Nicotina
Tipo de tratamento
- Farmacológico
- Terapias
- Outros
Canais de distribuição
- Online
- Off-line
Utilizador final
- Geração Z
- Geração Y
- Geração X
- Geração Silenciosa
Cessação tabágica e análise regional do mercado de dependência de nicotina/insights
O mercado de cessação tabágica e de dependência de nicotina é analisado e são fornecidos insights e tendências do tamanho do mercado por país, tipo de produto, tipo de tratamento, canal de distribuição e utilizador final, como mencionado acima.
Os países abrangidos no relatório de mercado para a cessação tabágica e dependência da nicotina são os EUA, o Canadá e o México.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas da América do Norte e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas domésticas e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Cenário competitivo e análise da quota de mercado para a cessação tabágica e dependência de nicotina
O cenário competitivo do mercado de cessação tabágica e de dependência da nicotina fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na América do Norte, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura e amplitude do produto, domínio da aplicação. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado da cessação tabágica e da dependência da nicotina.
Alguns dos principais players que operam no mercado da cessação tabágica e da dependência da nicotina são:
- Marcas Imperiais (Reino Unido)
- 22nd Century Group, Inc (EUA)
- (EUA)
- Reddy's Laboratories Ltd (Índia)
- Glaxosmithkline Plc. (REINO UNIDO)
- British American Tobacco (Reino Unido)
- Cambrex Corporation (EUA)
- (EUA)
- Fertin Pharma (Dinamarca)
- Johnson & Johnson privada limitada (EUA)
- Perrigo Company Plc (Irlanda)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRODUCT TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END-USER COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 IMPORT-EXPORT DATA
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING ADOPTION OF E-CIGARETTES IS EXPECTED TO FUEL THE GROWTH OF THE MARKET
5.1.2 GROWING AWARENESS AMONG POPULATION OWING TO INCREASING DISEASES FROM SMOKING
5.1.3 ANTI-SMOKING POLICIES BY GOVERNMENT IS EXPECTED TO BOOST THE MARKET
5.2 RESTRAINTS
5.2.1 ADVERSE EFFECTS OF SMOKING CESSATION PRODUCTS
5.2.2 REGULATIONS ON E-CIGARETTES
5.3 OPPORTUNITIES
5.3.1 UNTAPPED ASIAN MARKET SUCH AS CHINA AND INDIA, AMONG OTHERS
5.3.2 INHALERS AND SPRAYS CAN BE AN OPPORTUNITY FOR SMOKING CESSATION PRODUCTS
5.4 CHALLENGE
5.4.1 LACK OF AWARENESS IN RURAL AREAS
6 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 WITH NICOTINE
6.2.1.1 E-CIGARETTES
6.2.1.2 NICOTINE PATCHES
6.2.1.3 NICOTINE GUMS
6.2.1.4 NICOTINE LOZENGES
6.2.1.4.1 REGULAR LOZENGES
6.2.1.4.2 MINI LOZENGES
6.2.1.4.3 SUBLINGUAL LOZENGES
6.2.1.5 NICOTINE TABLETS
6.3 WITHOUT NICOTINE
6.3.1.1 CHANTIX (VARENICLINE)
6.3.1.2 CYTISINE
6.3.1.3 ZYBAN (BUPROPION)
7 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE
7.1 OVERVIEW
7.2 PHARMACOLOGICAL
7.3 THERAPIES
7.4 OTHERS
8 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 OFFLINE
8.2.1 DE-ADDICTION CENTERS
8.2.2 HOSPITAL PHARMACIES
8.2.3 RETAIL PHARMACIES
8.2.4 RETAIL STORES
8.2.5 OTHERS
8.3 ONLINE
9 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER
9.1 OVERVIEW
9.2 MILLENNIALS
9.3 MILLENNIALS END-USER, BY PRODUCT TYPE
9.3.1 WITH NICOTINE
9.3.2 WITHOUT NICOTINE
9.4 GENERATION Z
9.5 GENERATION Z END-USER, BY PRODUCT TYPE
9.5.1 WITH NICOTINE
9.5.2 WITHOUT NICOTINE
9.6 GENERATION X
9.7 GENERATION X END-USER, BY PRODUCT TYPE
9.7.1 WITH NICOTINE
9.7.2 WITHOUT NICOTINE
9.8 SILENT GENERATION
9.9 SILENT GENERATION END-USER, BY PRODUCT TYPE
9.9.1 WITH NICOTINE
9.9.2 WITHOUT NICOTINE
10 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO
11 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.2 MERGERS & ACQUISITIONS
11.3 NEW PRODUCT DEVELOPMENT & APPROVALS
11.4 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 SWOT ANALYSIS AND DATA BRIDGE MARKET RESEARCH ANALYSIS
12.1 SWOT ANALYSIS
12.1.1 STRENGTH: STRONG GEOGRAPHICAL PRESENCE
12.1.2 WEAKNESS: LIMTED PRODUCT PORTFOLIO
12.1.3 OPPORTUNITY: INCREASING INVESTMENT IN R&D EXPENDITURE
12.1.4 THREAT: STRINGENT RULES AND REGULATIONS
12.2 DATABRIDGE MARKET RESEARCH ANALYSIS
13 COMPANY PROFILE
13.1 IMPERIAL BRANDS
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT UPDATE
13.2ND CENTURY GROUP, INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT UPDATES
13.3 PFIZER INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 BRAND PORTFOLIO
13.3.5 RECENT UPDATE
13.4 DR. REDDY’S LABORATORIES LTD.
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 BRAND PORTFOLIO
13.4.5 RECENT UPDATE
13.5 GLAXOSMITHKLINE PLC.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT UPDATE
13.6 ALKALON A/S
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT UPDATE
13.7 BRITISH AMERICAN TOBACCO
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT UPDATES
13.8 CAMBREX CORPORATION
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT UPDATE
13.9 CIPLA INC.
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 BRAND PORTFOLIO
13.9.4 RECENT UPDATE
13.1 FERTIN PHARMA
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT UPDATE
13.11 JAPAN TOBACCO INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT UPDATE
13.12 JOHNSON & JOHNSON SERVICES, INC.
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT UPDATE
13.13 PERRIGO COMPANY PLC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT UPDATE
13.14 STRIDES CONSUMER PRIVATE LIMITED
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT UPDATES
13.15 TAKEDA CONSUMER HEALTHCARE COMPANY LIMITED
13.15.1 COMPANY SNAPSHOT
13.15.2 PRODUCT PORTFOLIO
13.15.3 RECENT UPDATE
14 QUESTIONNAIRE
15 CONCLUSION
16 RELATED REPORTS
Lista de Tabela
LIST OF TABLES
TABLE 1 IMPORT DATA OF MANUFACTURED TOBACCO AND MANUFACTURED TOBACCO SUBSTITUTES AND "HOMOGENISED" OR "RECONSTITUTED" TOBACCO, TOBACCO EXTRACTS AND TOBACCO ESSENCES (EXCLUDING CIGARS, INCL. CHEROOTS, CIGARILLOS AND CIGARETTES); HS CODE - 2403 (USD THOUSAND)
TABLE 2 EXPORT DATA OF MANUFACTURED TOBACCO AND MANUFACTURED TOBACCO SUBSTITUTES AND "HOMOGENISED" OR "RECONSTITUTED" TOBACCO, TOBACCO EXTRACTS AND TOBACCO ESSENCES (EXCLUDING CIGARS, INCL. CHEROOTS, CIGARILLOS AND CIGARETTES); HS CODE - 2403 (USD THOUSAND)
TABLE 3 USERS OF E-CIGARETTES, U.K., 2014-2019 (%)
TABLE 4 RISK REDUCTION ON SMOKING CESSATION
TABLE 5 RISK REDUCTION ON SMOKING CESSATION
TABLE 6 REGULATIONS OF DIFFERENT COUNTRIES
TABLE 7 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 8 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 9 NORTH AMERICA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (MILLION UNITS)
TABLE 10 NORTH AMERICA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 NORTH AMERICA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 12 NORTH AMERICA NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 13 NORTH AMERICA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (MILLION UNITS)
TABLE 14 NORTH AMERICA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 NORTH AMERICA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 16 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 17 NORTH AMERICA PHARMACOLOGICAL IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 NORTH AMERICA THERAPIES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19 NORTH AMERICA OTHERS IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 21 NORTH AMERICA OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 NORTH AMERICA OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 23 NORTH AMERICA ONLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 24 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 25 NORTH AMERICA MILLENNIALS END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 26 NORTH AMERICA MILLENNIALS END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 27 NORTH AMERICA GENERATION Z END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 NORTH AMERICA GENERATION Z END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 29 NORTH AMERICA GENERATION X END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 30 NORTH AMERICA GENERATION X END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 31 NORTH AMERICA SILENT GENERATION END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 32 NORTH AMERICA SILENT GENERATION END-USER IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 33 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY COUNTRY, 2018-2027 (MILLION UNITS)
TABLE 34 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 35 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 36 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 37 NORTH AMERICA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 38 NORTH AMERICA NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 39 NORTH AMERICA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 40 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 41 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 42 NORTH AMERICA OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 43 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 44 NORTH AMERICA MILLENNIALS IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 45 NORTH AMERICA GENERATION Z IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 46 NORTH AMERICA GENERATION X IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 47 NORTH AMERICA SILENT GENERATION IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 48 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 49 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 50 U.S. WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 51 U.S. NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 52 U.S. WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 53 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 54 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 55 U.S. OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 56 U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 57 U.S. IN MILLENNIALS SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 58 U.S. GENERATION Z IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 59 U.S. GENERATION X IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 60 U.S. SILENT GENERATION IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 61 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 62 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 63 CANADA WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 64 CANADA NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 65 CANADA WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 66 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 67 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 68 CANADA OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 69 CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 70 CANADA MILLENNIALS IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 71 CANADA GENERATION Z IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 72 CANADA GENERATION X IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 73 CANADA SILENT GENERATION IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 74 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (MILLION UNITS)
TABLE 75 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 76 MEXICO WITH NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 77 MEXICO NICOTINE LOZENGES IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY NICOTINE LOZENGES WITH NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 78 MEXICO WITHOUT NICOTINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY WITHOUT NICOTINE PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 79 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 80 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 81 MEXICO OFFLINE IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 82 MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY END-USER, 2018-2027 (USD MILLION)
TABLE 83 MEXICO MILLENNIALS IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 84 MEXICO GENERATION Z IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 85 MEXICO GENERATION X IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 86 MEXICO SILENT GENERATION IN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
Lista de Figura
LIST OF FIGURES
FIGURE 1 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: RESEARCH SNAPSHOT
FIGURE 4 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: THE PRODUCT TYPE LIFE LINE CURVE
FIGURE 7 MULTIVARIATE MODELLING FOR NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET
FIGURE 8 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: DBMR MARKET POSITION GRID
FIGURE 10 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: MARKET END-USER COVERAGE GRID
FIGURE 11 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 12 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: SEGMENTATION
FIGURE 13 GROWING AWARENESS AMONG POPULATION OWING TO INCREASING DISEASES FROM SMOKING IS A DRIVER OF SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 14 WITH NICOTINE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET IN 2020 TO 2027
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES IN NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET
FIGURE 16 POPULATION OF ADULT E-CIGARETTES USERS, U.K.,2014-2019 (PERCENTAGE)
FIGURE 17 CHINA PREVELANCE RATE OF SMOKING, MALE VS FEMALE, 2015 (IN PERCENTAGE)
FIGURE 18 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY PRODUCT TYPE, 2019
FIGURE 19 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY TREATMENT TYPE, 2019
FIGURE 20 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY DISTRIBUTION CHANNEL, 2019
FIGURE 21 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY END-USER, 2019
FIGURE 22 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: SNAPSHOT (2019)
FIGURE 23 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY COUNTRY (2019)
FIGURE 24 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY COUNTRY (2020 & 2027)
FIGURE 25 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY COUNTRY (2019 & 2027)
FIGURE 26 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY PRODUCT TYPE (2020-2027)
FIGURE 27 NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: COMPANY SHARE 2019 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.